1. Bortezomib consolidation following autologous transplant in younger and older patients with newly diagnosed multiple myeloma in two phase III trials. (19th July 2019) Authors: Straka, Christian; Knop, Stefan; Vogel, Martin; Müller, Jürgen; Kropff, Martin; Metzner, Bernd; Langer, Christian; Sayer, Herbert; Jung, Wolfram; Dürk, Heinz A.; Salwender, Hans; Wandt, Hannes; Bassermann, Florian; Gramatzki, Martin; Rösler, Wolf; Wolf, Hans‐Heinrich; Brugger, Wolfram; Fischer, T... Journal: European journal of haematology Issue: Volume 103:Number 3(2019) Page Start: 255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Granulocyte-colony stimulating factor response is superior to neutropenia duration in predicting the risk of infection after high-dose chemotherapy for myeloma and lymphoma. Issue 2 (February 2015) Authors: Straka, Christian; Salwender, Hans; Schnabel, Brigitte; Sandherr, Michael; Wandt, Hannes; Hübel, Kai; Scheid, Christof; Metzner, Bernd; Hentrich, Marcus; Franke, Daniel; Weidenegger, Gloria; Freund, Mathias; Sezer, Orhan; Einsele, Hermann; Hinke, Axel; Emmerich, Bertold Journal: Leukemia & lymphoma Issue: Volume 56:Issue 2(2015:Feb.) Page Start: 368 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗